Decline in the rate of hospital mortality from acute myocardial infarction: Impact of changing management strategies

American Heart Journal

Volumn 131, Issue 2, 1996, Pages 250-256

  Gheorghiade, Mihai ^a   Ruzumna, Paul ^a   Borzak, Steven ^b   Havstad, Sue ^c   Ali, Abbas ^b   Goldstein, Sidney ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

^c 524 Wesley Pavilion ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CORONARY CARE UNIT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030043428     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90349-X     Document Type: Article

References (36)

1. Day HW. An intensive coronary care area. Chest 1963;25:423-7.
2. Brown KWG, MacMillan RL, Forbath N. Coronary unit: an intensive care center for acute myocardial infarction. Lancet 1963;2:349-52.
3. Meltzer LE, Kitchell JB. The incidence of arrhythmias associated with acute myocardial infarction. Prog Cardiovasc Dis 1966;9:50-63.
4. Goldman L, Cook F, Hashimoto B, Stone P, Muller Y, Loscalzo A. Evidence that hospital care for acute myocardial infarction has not contributed to the decline in coronary mortality between 1973-1974 and 1978-1979. Circulation 1982;65:936-42.
5. ISAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity, and infarct size at 21 days. N Engl J Med 1986;314:1465-71.
6. Gruppo Italiano per lo Studio Della Streptochinasi Nell'infarcto Micardio (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-401.
7. ISIS-2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-60.
8. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
9. Lamas GA, Pfeffer MA, Hamm P, Wertheimer J, Rouleau JL, Braunwald E for the SAVE investigators. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? N Engl J Med 1992;327:241-7.
10. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: treatments for acute myocardial infarction. JAMA 1992;268:240-8.
11. Held PH, Yusuf S, Furburg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ 1989; 299:1187-92.
12. Teo KK, Yusuf S, Furburg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 1993;270:1589-95.
13. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized, controlled trials. JAMA 1988;260:1910-6.
14. Pashos CL, Normand S-LT, Garfinkle JB, Newhouse JP, Epstein AM, McNeil BJ. Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. J Am Coll Cardiol 1994;23:1023-30.
15. Moosvi AR, Khaja F, Villaneuva L, Gheorghiade M, Douthat L, Goldstein S. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 1992; 19:907-14.
16. Grines CL, Browne KF, Marco J, Rothman D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis G, Vlietstra RE, Strzelecki M, Puchrowicz-Ochocki S, O'Neill WW, for the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
17. TIMI Research Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the thrombolysis in myocardial ischemia (TIMI) II trial. N Engl J Med 1989;320:618-27.
18. Pashos CL, Newhouse JP, McNeil BJ. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990. JAMA 1993;270:1832-6.
19. Williams DO, Braunwald E, Knatterud G, Babb J, Bresnahan J, Greenberg MA, Raizner A, Wasserman A, Robertson T, Ross R. One-year results of the thrombolysis in myocardial infarction investigation (TIMI) phase II trial. Circulation 1992;85:533-42.
20. Gheorghiade M, Anderson J, Rosman H, Lakier J, Velardo B, Goldberg D, Friedman A, Schultz L, Tilley B, Goldstein S. Risk identification at the time of admission to coronary care unit in patients with suspected myocardial infarction. AM HEART J 1988;116:1212-7.
21. Greenland S. Modeling and variable selection in epidemiologic analyses. Am J Public Health 1989;79:340-9.
22. Edlavitch SA, Crow R, Burke GL, Baxter J. Secular trends in Q wave and non-Q wave acute myocardial infarction: The Minnesota Heart Survey. Circulation 1991;83:492-503.
23. Huey BL, Gheorghiade M, Crampton RS, Beller GA, Kaiser DL, Watson DD, Nygard TW, Craddock GB, Sayre SL, Gibson RS. Acute non-Q wave myocardial infarction associated with early ST segment elevation: evidence for spontaneous coronary reperfusion and implications for thrombolytic trials. J Am Coll Cardiol 1987;9:18-25.
24. Vatner ST, Baig H, Manders WT, Maroko PR. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Invest 1977;61:1048-55.
25. Robert R. Enzymatic estimation of infarct size: thrombolysis induced its demise: will it now rekindle its renaissance? Circulation 1990;81:707-10.
26. Antman EM, Berlin JA. Declining incidence of ventricular fibrillation in myocardial infarction: implications for the prophylactic use of lidocaine. Circulation 1992;86:764-73.
27. Chiriboga DE, Yarzebski J, Goldberg RJ, Chen Z, Gurwitz J, Gore JM, Alpert JS, Dalen JE. A community-wide perspective of gender differences and temporal trends in the use of diagnostic and revascularization procedures for acute myocardial infarction. Am J Cardiol 1993; 71:268-73.
28. Ranjadayalan K, Umachandran V, Timmis AD. Clinical impact of introducing thrombolytic and aspirin therapy into the management policy of a coronary care unit. Am J Med 1992;92:233-8.
29. Meinertz T, Kasper W, Schumacher M, Just H. The German multicenter trial of amisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction. Am J Cardiol 1988;62:347-51.
30. Goldberg RJ, Gore JM, Alpert JS, Osganian V, DeGroot J, Bade J, Chen Z, Frid D, Dalen JE. Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991;325:1117-22.
31. Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
32. Bates ER, Topol EJ. Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and shock. J Am Coll Cardiol 1991;18:1077-84.
33. Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, Jacobs A, Slater J, Miller D, Wasserman H, Menegus MA, Talley D, McKinlay S, Sanborn T, LeJemtel T, and the SHOCK Registry Investigators. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry. Circulation 1995;91:873-81.
34. Mickels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 1995;91:476-85.
35. Naylor CD, Chen E. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: the Ontario experience 1981 to 1991. J Am Coll Cardiol 1994;24:1431-8.
36. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, Rubison RM, Tiefenbrunn AJ, Weaver WD, for the Participants in the National Registry of Myocardial Infarction. Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation 1994; 90:2103-14.